Literature DB >> 9598476

The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis.

C L Parsons1, M Greenberger, L Gabal, M Bidair, G Barme.   

Abstract

PURPOSE: We determined whether intravesical potassium absorption in normal bladders correlates with increased sensory urgency, and corroborated the hypothesis that mucus is important in the regulation of epithelial permeability. We compared sensory nerve provocative ability of sodium versus potassium, and determined whether intravesical potassium sensitivity discriminates patients with interstitial cystitis from normal subjects and those with other sensory disorders of the bladder.
MATERIALS AND METHODS: A total of 231 patients with interstitial cystitis and 41 normal subjects underwent intravesical challenge with 40 ml. water and then 40 ml. of 40 mEq./100 ml. potassium chloride. Subjective responses of urgency or pain stimulation were recorded on a scale of 0 to 5. In 19 normal subjects potassium absorption was measured at baseline, after injury of the bladder mucus with protamine, after heparin treatment to reverse mucus damage and then for a final time. These subjects simultaneously recorded the symptoms of sensory urgency and pain at baseline, after protamine and after heparin. Another group of normal volunteers underwent a challenge with sodium versus potassium to determine which cation was more provocative. Patients with bladder outlet obstruction secondary to benign prostatic hyperplasia (BPH), detrusor instability, and acute and chronic urinary tract infection but no current infection were also evaluated for potassium sensitivity.
RESULTS: Neither normal subjects nor patients with interstitial cystitis reacted to water administered intravesically. There was marked sensitivity to intravesical potassium in 75% of patients with interstitial cystitis versus 4% of controls (p <0.01). Only 1 patient with BPH responded to potassium and none of the 5 with chronic urinary tract infection responded. All 4 patients (100%) with a current acute urinary tract infection reacted positively to the potassium challenge. Of 16 patients with detrusor instability 25% responded. Normal subjects had minimal sensitivity to potassium before (11%) and markedly increased sensitivity after (79%) protamine treatment, and these symptoms were reversed by heparin in 42%. Potassium absorption directly correlated with symptoms (0.4, 3.0 and 1.3 mEq. before and after protamine, and after heparin reversal, respectively). In regard to sodium versus potassium provocation, potassium was far more provocative for causing urgency after protamine (10 versus 90%). Neither group underwent provocation before protamine.
CONCLUSIONS: Chronic diffusion of urinary potassium into the bladder interstitium may induce sensory symptoms, damage tissue and be a major toxic factor in the pathogenesis of interstitial cystitis. Intravesical potassium sensitivity is a reliable method for detecting abnormal epithelial permeability. It discriminates between patients with interstitial cystitis and normal subjects with intact epithelial function, and it is a useful diagnostic test for interstitial cystitis. Potassium sensitivity correlates with increased potassium absorption in normal subjects, and potassium is far more provocative than sodium. Potassium sensitivity is also present in acute urinary tract infection and occasionally detrusor instability but not in BPH or chronic urinary tract infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9598476

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  54 in total

1.  Increased urothelial paracellular transport promotes cystitis.

Authors:  Nicolas Montalbetti; Anna C Rued; Dennis R Clayton; Wily G Ruiz; Sheldon I Bastacky; H Sandeep Prakasam; Amity F Eaton; F Aura Kullmann; Gerard Apodaca; Marcelo D Carattino
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-30

Review 2.  Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Aram Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

3.  Is the potassium sensitivity test a valid and useful test for the diagnosis of interstitial cystitis? Against.

Authors:  Philip Hanno
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-04-15

4.  Argument for the use of the potassium sensitivity test in the diagnosis of interstitial cystitis. For.

Authors:  C Lowell Parsons
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-06-02

5.  Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity?

Authors:  Bernard T Haylen; Naven Chetty; Vanessa Logan; Serena Schulz; Louise Verity; Matthew Law; Jialun Zhou
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-07-06

Review 6.  Mechanisms of disease: involvement of the urothelium in bladder dysfunction.

Authors:  Lori A Birder; William C de Groat
Journal:  Nat Clin Pract Urol       Date:  2007-01

7.  Diagnosis of interstitial cystitis June 2007.

Authors:  Lesley K Carr; Jacques Corcos; J Curtis Nickel; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

8.  In the absence of overt urothelial damage, chondroitinase ABC digestion of the GAG layer increases bladder permeability in ovariectomized female rats.

Authors:  Robert E Hurst; Samuel Van Gordon; Karl Tyler; Bradley Kropp; Rheal Towner; HsuehKung Lin; John O Marentette; Jane McHowat; Ehsan Mohammedi; Beverley Greenwood-Van Meerveld
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-24

9.  Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium.

Authors:  Bikramjit Chopra; Stacey R Barrick; Susan Meyers; Jonathan M Beckel; Mark L Zeidel; Anthony P D W Ford; William C de Groat; Lori A Birder
Journal:  J Physiol       Date:  2004-12-02       Impact factor: 5.182

Review 10.  [Interstitial cystitis. Current aspects of diagnosis and therapy].

Authors:  A Loch; U Stein
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.